Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 17 Aug 2026

In an interview, Bharaddia discusses where valuations still offer opportunities, the emerging earnings recovery, sectors that could outperform, risks around expensive capex and AI-related themes, and how investors should position portfolios over the next 6–12 months.Edited excerpts from a chat: ...

1 publisher has reported this development. Each act of reporting is below, cited.

The record

In an interview, Bharaddia discusses where valuations still offer opportunities, the emerging earnings recovery, sectors that could outperform, risks around expensive capex and AI-related themes, and how investors should position portfolios over the next 6–12 months.Edited excerpts from a chat: ...

indiatimes.com16 Aug 2026

A single act of reporting so far, corroborating sources join this record as they publish.

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.